Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Cannabidiol
Therapeutic Area : Neurology
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
BRC Doses First Patient in Cannabinoid Therapy Study for Complex Regional Pain Syndrome
Details : BRC-002 (cannabidiol) is a first-in-class therapeutic product candidate aiming to address pain and co-morbidities of Complex Regional Pain Syndrome.
Product Name : BRC-002
Product Type : Controlled Substance
Upfront Cash : Inapplicable
March 10, 2024
Lead Product(s) : Cannabidiol
Therapeutic Area : Neurology
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
